{"id":2168,"date":"2013-08-23T06:36:11","date_gmt":"2013-08-23T06:36:11","guid":{"rendered":"http:\/\/test-medrazgl.aed-baza.si\/?p=2168"},"modified":"2013-08-23T06:36:27","modified_gmt":"2013-08-23T06:36:27","slug":"2168","status":"publish","type":"post","link":"https:\/\/medrazgl.si\/en\/2168\/","title":{"rendered":"Indicators of Activated Coagulation in Patients with Venous Thrombosis and Mutation in the Genes for Prothrombin and Factor V"},"content":{"rendered":"
\n

Mutation in the prothrombin gene (G20120A) and in the factor V gene (G1691A), which is manifested as resistance to the activated protein C (nAPC), are important risk factors for throm\u00adboembolic disease because they are presumably connected with activated coagulation. The prevalence of both mutations shows a significant geographical distribution. The prevalence of prothrombin mutation among patients with deep vein thrombosis is not yet known in Slovenia. The aim of our research was to determine the prevalence of prothrombin gene muta\u00adtion in patients with deep vein thrombosis and to study the possible connection between this mutation, mutation in factor V and higher concentrations of markers of activated coagula\u00adtion: a peptide released from prothrombin during its activation to thrombin (F1+2), a complex between thrombin and antithrombin (TAT) and degradation products of cross-linked fibrin (D-dimers). Our research was based on the hypothesis that the prevalence of prothrombin mutation is similar to that in neighboring populations. Prothrombin mutation and mutation in factor V are connected to higher concentrations of markers of activated coagulation in patients with deep vein thrombosis. 88 patients with deep vein thrombosis were included in the retrospective study. DNA was isolated and DNA analysis was performed. Mutation in the factor V gene was determined as nAPC. The concentrations of markers of activated coag\u00adulation were measured using enzyme immunoassays. The prevalence of prothrombin gene mutation was 6.8%, that of nAPC was 23.3% and that of both was 3.5%, which is in concordance with the prevalence of both mutations in patients with deep vein thrombosis in neighboring populations. The differences in the concentrations of F1+2, TAT and D-dimers among patients with different genotypes were not statistically significant. F1+2 was measured in patients with or without prothrombin mutation: 1.5 vs. 1.0 nmol\/L (p = 0.21), TAT: 6.3 vs. 2.2 \u03bcg\/L (p = 0.16) and D-dimers: 45 vs. 37 \u03bcg\/L (p = 0.88). F1+2 in patients with and without nAPC was as fol\u00adlows: 1.2 vs. 1.0 nmol\/L (p = 0.95), TAT: 2.2 vs. 2.2 \u03bcg\/L (p = 0.86), D-dimers: 26 vs. 82 \u03bcg\/L (p = 0.08). In patients with both mutations or without any mutation it was: 1.4 vs. 1.0 nmol\/L (p = 0.66), TAT: 2.4 vs. 2.2 \u03bcg\/L (p = 0.83), D-dimers: 21 vs. 39 \u03bcg\/L (p = 0.28, all values are medians). Neither of the two mutations nor the combination of both influenced the con\u00adcentrations of markers of activated coagulation.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Mutation in the prothrombin gene (G20120A) and in the factor V gene (G1691A), which is manifested as resistance to the activated protein C (nAPC), are important risk factors for throm\u00adboembolic disease because they are presumably connected with activated coagulation. The prevalence of both mutations shows a significant geographical distribution. The prevalence of prothrombin mutation among […]<\/p>\n","protected":false},"author":19,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[355,407,426],"tags":[],"class_list":["post-2168","post","type-post","status-publish","format-standard","hentry","category-2-2003-archive","category-clinical-research-paper","category-internal-medicine"],"acf":[],"yoast_head":"\nIndicators of Activated Coagulation in Patients with Venous Thrombosis and Mutation in the Genes for Prothrombin and Factor V - Dru\u0161tvo Medicinski razgledi<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Indicators of Activated Coagulation in Patients with Venous Thrombosis and Mutation in the Genes for Prothrombin and Factor V - Dru\u0161tvo Medicinski razgledi\" \/>\n<meta property=\"og:description\" content=\"Mutation in the prothrombin gene (G20120A) and in the factor V gene (G1691A), which is manifested as resistance to the activated protein C (nAPC), are important risk factors for throm\u00adboembolic disease because they are presumably connected with activated coagulation. The prevalence of both mutations shows a significant geographical distribution. The prevalence of prothrombin mutation among […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/\" \/>\n<meta property=\"og:site_name\" content=\"Dru\u0161tvo Medicinski razgledi\" \/>\n<meta property=\"article:published_time\" content=\"2013-08-23T06:36:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2013-08-23T06:36:27+00:00\" \/>\n<meta name=\"author\" content=\"\u0160pela Tev\u017ei\u010d\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u0160pela Tev\u017ei\u010d\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\\\/\"},\"author\":{\"name\":\"\u0160pela Tev\u017ei\u010d\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/a9c9f729f51105c2bf5cb24afcf1beb2\"},\"headline\":\"Indicators of Activated Coagulation in Patients with Venous Thrombosis and Mutation in the Genes for Prothrombin and Factor V\",\"datePublished\":\"2013-08-23T06:36:11+00:00\",\"dateModified\":\"2013-08-23T06:36:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\\\/\"},\"wordCount\":393,\"commentCount\":0,\"articleSection\":[\"2\",\"Clinical research paper\",\"Internal Medicine\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/medrazgl.si\\\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\\\/\",\"url\":\"https:\\\/\\\/medrazgl.si\\\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\\\/\",\"name\":\"Indicators of Activated Coagulation in Patients with Venous Thrombosis and Mutation in the Genes for Prothrombin and Factor V - Dru\u0161tvo Medicinski razgledi\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#website\"},\"datePublished\":\"2013-08-23T06:36:11+00:00\",\"dateModified\":\"2013-08-23T06:36:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/a9c9f729f51105c2bf5cb24afcf1beb2\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medrazgl.si\\\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/medrazgl.si\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Indicators of Activated Coagulation in Patients with Venous Thrombosis and Mutation in the Genes for Prothrombin and Factor V\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#website\",\"url\":\"https:\\\/\\\/medrazgl.si\\\/\",\"name\":\"Dru\u0161tvo Medicinski razgledi\",\"description\":\"Dru\u0161tvo Medicinski razgledi\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medrazgl.si\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/a9c9f729f51105c2bf5cb24afcf1beb2\",\"name\":\"\u0160pela Tev\u017ei\u010d\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3731c7de393bc4416a5d78b8bb8fff9c6d8b2c1ecceff0b0f4c341d2eedbb25b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3731c7de393bc4416a5d78b8bb8fff9c6d8b2c1ecceff0b0f4c341d2eedbb25b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3731c7de393bc4416a5d78b8bb8fff9c6d8b2c1ecceff0b0f4c341d2eedbb25b?s=96&d=mm&r=g\",\"caption\":\"\u0160pela Tev\u017ei\u010d\"},\"url\":\"https:\\\/\\\/medrazgl.si\\\/en\\\/author\\\/spela-tevzic\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Indicators of Activated Coagulation in Patients with Venous Thrombosis and Mutation in the Genes for Prothrombin and Factor V - Dru\u0161tvo Medicinski razgledi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/","og_locale":"en_US","og_type":"article","og_title":"Indicators of Activated Coagulation in Patients with Venous Thrombosis and Mutation in the Genes for Prothrombin and Factor V - Dru\u0161tvo Medicinski razgledi","og_description":"Mutation in the prothrombin gene (G20120A) and in the factor V gene (G1691A), which is manifested as resistance to the activated protein C (nAPC), are important risk factors for throm\u00adboembolic disease because they are presumably connected with activated coagulation. The prevalence of both mutations shows a significant geographical distribution. The prevalence of prothrombin mutation among […]","og_url":"https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/","og_site_name":"Dru\u0161tvo Medicinski razgledi","article_published_time":"2013-08-23T06:36:11+00:00","article_modified_time":"2013-08-23T06:36:27+00:00","author":"\u0160pela Tev\u017ei\u010d","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u0160pela Tev\u017ei\u010d","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/#article","isPartOf":{"@id":"https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/"},"author":{"name":"\u0160pela Tev\u017ei\u010d","@id":"https:\/\/medrazgl.si\/#\/schema\/person\/a9c9f729f51105c2bf5cb24afcf1beb2"},"headline":"Indicators of Activated Coagulation in Patients with Venous Thrombosis and Mutation in the Genes for Prothrombin and Factor V","datePublished":"2013-08-23T06:36:11+00:00","dateModified":"2013-08-23T06:36:27+00:00","mainEntityOfPage":{"@id":"https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/"},"wordCount":393,"commentCount":0,"articleSection":["2","Clinical research paper","Internal Medicine"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/","url":"https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/","name":"Indicators of Activated Coagulation in Patients with Venous Thrombosis and Mutation in the Genes for Prothrombin and Factor V - Dru\u0161tvo Medicinski razgledi","isPartOf":{"@id":"https:\/\/medrazgl.si\/#website"},"datePublished":"2013-08-23T06:36:11+00:00","dateModified":"2013-08-23T06:36:27+00:00","author":{"@id":"https:\/\/medrazgl.si\/#\/schema\/person\/a9c9f729f51105c2bf5cb24afcf1beb2"},"breadcrumb":{"@id":"https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medrazgl.si\/kazalci-aktivirane-koagulacije-pri-bolnikih-z-vensko-trombozo-in-mutacijo-v-genu-za-protrombin-in-faktor-v\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medrazgl.si\/en\/"},{"@type":"ListItem","position":2,"name":"Indicators of Activated Coagulation in Patients with Venous Thrombosis and Mutation in the Genes for Prothrombin and Factor V"}]},{"@type":"WebSite","@id":"https:\/\/medrazgl.si\/#website","url":"https:\/\/medrazgl.si\/","name":"Dru\u0161tvo Medicinski razgledi","description":"Dru\u0161tvo Medicinski razgledi","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medrazgl.si\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/medrazgl.si\/#\/schema\/person\/a9c9f729f51105c2bf5cb24afcf1beb2","name":"\u0160pela Tev\u017ei\u010d","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/3731c7de393bc4416a5d78b8bb8fff9c6d8b2c1ecceff0b0f4c341d2eedbb25b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3731c7de393bc4416a5d78b8bb8fff9c6d8b2c1ecceff0b0f4c341d2eedbb25b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3731c7de393bc4416a5d78b8bb8fff9c6d8b2c1ecceff0b0f4c341d2eedbb25b?s=96&d=mm&r=g","caption":"\u0160pela Tev\u017ei\u010d"},"url":"https:\/\/medrazgl.si\/en\/author\/spela-tevzic\/"}]}},"_links":{"self":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts\/2168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/comments?post=2168"}],"version-history":[{"count":0,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts\/2168\/revisions"}],"wp:attachment":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/media?parent=2168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/categories?post=2168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/tags?post=2168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}